Involvement of T lymphocytes in the placentae with villitis of unknown etiology from pregnancies complicated with preeclampsia

References

• Redline RW, Patterson P. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007;38:1439–46
   PubMed Web of Science ®Google Scholar
• Kim JS, Romero R, Kim MR, et al. Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology. Histopathology 2008;52:457–64
   PubMed Web of Science ®Google Scholar
• Myerson D, Parkin RK, Benirschke K, et al. The pathogenesis of villitis of unknown etiology: analysis with a new conjoint immunohistochemistry-in situ hybridization procedure to identify specific maternal and fetal cells. Pediatr Dev Pathol 2006;9:257–65
   PubMed Web of Science ®Google Scholar
• Labarrere CA, Faulk WP. MHC class II reactivity of human villous trophoblast in chronic inflammation of unestablished etiology. Transplantation 1990;50:812–16
   PubMed Web of Science ®Google Scholar
• Brito H, Juliano P, Altemani C, Altemani A. Is the immunohistochemical study of the inflammatory infiltrate helpful in distinguishing villitis of unknown etiology from non-specific infection villitis? Placenta 2005;26:839–41
   PubMed Web of Science ®Google Scholar
• Kapur P, Rakheja D, Gomez AM, et al. Characterization of inflammation in syphilitic villitis and in villitis of unknown etiology. Pediatr Dev Pathol 2004;7:453–8
   PubMed Web of Science ®Google Scholar
• Scazzocchio E, Figueras F. Contemporary prediction of preeclampsia. Curr Opin Obstet Gynecol 2011;23:65–71
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Banhidy F. Chronic hypertension in pregnancy. Curr Opin Obstet Gynecol 2011;23:76–81
   PubMed Web of Science ®Google Scholar
• Steegers EA, von DP, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Placental stress and preeclampsia: a revised view. Placenta 2009;30:38–42
   PubMed Web of Science ®Google Scholar
• Fehervari Z, Sakaguchi S. CD4+ T regs and immune control. J Clin Invest 2004;114:1209–17
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol 2010;63:601–10
   PubMed Web of Science ®Google Scholar
• Prusac IK, Zekic TS, Roje D. Apoptosis, proliferation and Fas ligand expression in placental trophoblast from pregnancies complicated by HELLP syndrome or pre-eclampsia. Acta Obstet Gynecol Scand 2011;90:1157–63
   PubMed Web of Science ®Google Scholar
• Bonett DG, Price RM. Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements. Psychol Methods 2002;7:370–83
   PubMed Web of Science ®Google Scholar
• R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2008. ISBN 3-900051-07-0, URL
   Google Scholar
• Hintze J. PASS 13. Kaysville (UT): NCSS, LLC; 2014
   Google Scholar
• Hafeez NA, Fouda M, Abdel Gawad ER, et al. The role of regulatory T cells in preeclampsia. Egypt J Immunol 2014;21:45–55
   PubMedGoogle Scholar
• Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010;159:109–19
   PubMed Web of Science ®Google Scholar
• Steinborn A, Haensch GM, Mahnke K, et al. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin Immunol 2008;129:401–12
   PubMed Web of Science ®Google Scholar
• Fischer A. Human immunodeficiency: connecting STAT3, Th17 and human mucosal immunity. Immunol Cell Biol 2008;86:549–51
   PubMed Web of Science ®Google Scholar
• Santner-Nanan B, Peek MJ, Khanam R, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009;183:7023–30
   PubMed Web of Science ®Google Scholar
• Prins JR, Boelens HM, Heimweg J, et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregn 2009;28:300–11
   PubMed Web of Science ®Google Scholar
• Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 2012;93:75–81
   PubMed Web of Science ®Google Scholar
• Katzman PJ, Murphy SP, Oble DA. Immunohistochemical analysis reveals an influx of regulatory T cells and focal trophoblastic STAT-1 phosphorylation in chronic villitis of unknown etiology. Pediatr Dev Pathol 2011;14:284–93
   PubMed Web of Science ®Google Scholar
• Saito S. Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia. Immunol Cell Biol 2010;88:615–17
   PubMed Web of Science ®Google Scholar
• Laresgoiti-Servitje E, Gomez-Lopez N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update 2010;16:510–24
   PubMed Web of Science ®Google Scholar
• Polanczyk MJ, Carson BD, Subramanian S, et al. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J Immunol 2004;173:2227–30
   PubMed Web of Science ®Google Scholar
• Phillips TA, Ni J, Pan G, et al. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol 1999;162:6053–9
   PubMed Web of Science ®Google Scholar
• Mellor AL, Sivakumar J, Chandler P, et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001;2:64–8
   PubMed Web of Science ®Google Scholar
• Hunt JS, Vassmer D, Ferguson TA, Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997;158:4122–8
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Le BK, Dominici M, et al. Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 2005;7:393–5
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815–22
   PubMed Web of Science ®Google Scholar
• Bifari F, Lisi V, Mimiola E, et al. Immune modulation by mesenchymal stem cells. Transfus Med Hemother 2008;35:194–204
   PubMed Web of Science ®Google Scholar
• Duffner UA, Maeda Y, Cooke KR, et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 2004;172:7393–8
   PubMed Web of Science ®Google Scholar
• Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 2011;141:715–24
   PubMed Web of Science ®Google Scholar
• Zenclussen AC, Gerlof K, Zenclussen ML, et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 2005;166:811–22
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Sakai M, Miyazaki S, et al. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004;10:347–53
   PubMed Web of Science ®Google Scholar